Hospital News and Research

RSS

Homecare advocates discuss the value and cost-effectiveness of home-based care

More than 250 providers of home medical equipment and services from across the U.S. met with members of Congress this week during the American Association for Homecare's Washington Legislative Conference.

6 Mar 2010

Study shows clear link between Vitamin D levels and accumulation of fat in muscle tissue

There's an epidemic in progress, and it has nothing to do with the flu. A ground-breaking study published in the March 2010 Journal of Clinical Endocrinology and Metabolism found an astonishing 59 per cent of study subjects had too little Vitamin D in their blood. Nearly a quarter of the group had serious deficiencies (less than 20 ng/ml) of this important vitamin.

6 Mar 2010

The Joint Commission provides 'The Gold Seal of Approval' to NYU Hospitals Center

NYU Langone Medical Center announced today that the NYU Hospitals Center received The Gold Seal of Approval by The Joint Commission, a national nonprofit organization responsible for certifying that some 17,000 U.S. healthcare institutions are following the very best practices in terms of patient care and safety. Accreditation by The Joint Commission, which must be re-earned every three years, signals to patients and staff alike that NYU Langone is meeting the commission’s exacting standards in such key areas as patient rights, quality of treatment, medication safety, and infection control.

6 Mar 2010

Researchers assess clinical and cost impacts of PPI utilization in hospitalized patients

Proton pump inhibitors (PPIs) are the most effective agents for treating acid related gastrointestinal (GI) disorders. The utilization of intravenous (IV) formulations of PPIs has dramatically increased in health care institutions for inappropriate indications, route of administration and length of treatment. This is associated with an increased cost burden, increased risk of IV related infections, and utilization of hospital resources.

6 Mar 2010

Postoperative complications more likely to occur at low-volume institutions

The frequency of post-operative complications following surgery for liver cancer is associated with a hospital having a low volume of liver surgery. Investigators at The Cancer Institute of New Jersey (CINJ) are presenting that finding at the 63rd Annual Society of Surgical Oncology Symposium taking place this week in St. Louis. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

6 Mar 2010

Inpatient integrative medicine program can have significant impact on pain: Study

Non-traditional therapies relieve pain among a wide range of hospitalized patients as much as 50 percent, according to a first-of-a-kind study in the Journal of Patient Safety.

6 Mar 2010

Study reports increased incidence of colorectal cancer in China

The incidence of colorectal cancer (CRC) in China is lower than that in the west countries, but has increased in recent years and become a substantial cancer burden in China, particularly in the more developed areas.

6 Mar 2010

Thymosin beta 4 improves neurological functional outcome

REGENERX BIOPHARMACEUTICALS, INC. announced that a research team from the Henry Ford Hospital in Detroit, MI reported that Thymosin beta 4 (Tβ4), administered to rats one day after embolic stroke, improved neurological functional outcome compared to control animals.

6 Mar 2010

Closing small bowel stomas: Minimal delay optimal

It is generally recommended that a temporary stoma be closed within 9-12 wk after its construction. However, because some patients poorly tolerate the temporary stoma owing to extracellular dehydration, difficult pouch fitting, parenteral nutrition requirement in cases when the stoma is very proximal, and psychological or social impact, it might be advisable to opt for early closure.

6 Mar 2010

Soluble Systems, SWAI launch TheraSkin to jumpstart healing in chronic and acute wounds

Soluble Systems, LLC and the Skin and Wound Allograft Institute, a wholly owned subsidiary of LifeNet Health, have signed a noteworthy agreement to launch TheraSkin™, a biologically active human skin allograft designed to jumpstart healing in chronic and acute wounds.

6 Mar 2010

Investigators disprove reports that well-fed children are more vulnerable to dengue virus

A new study led by St. Jude Children's Research Hospital investigators disproves reports that well-fed children are more vulnerable to the dengue virus. Mosquitoes spread the virus, which can cause severe flu-like symptoms and sometimes lethal complications.

5 Mar 2010

XI to showcase HyGreen hand hygiene system at the Fifth Decennial International Conference

Xhale Innovations announced today that it will showcase its hand hygiene system, HyGreen™, at the Fifth Decennial International Conference on Healthcare-Associated Infections to be held March 18 – 22, 2010. This real-time hand hygiene recording and reminding system is designed to assist healthcare facilities with their infection control programs.

5 Mar 2010

MicroPhage seeks FDA clearance for MRSA/MSSA Blood Culture Test, submits clinical study data

MicroPhage announced that it has submitted human data from a pivotal clinical study of its ‘Microphage MRSA/MSSA Blood Culture Test’ to support a U.S. Food and Drug Administration (FDA) 510(k) premarket notification process. The first of MicroPhage’s instrument-free, rapid tests is based on the Company’s patented Bacteriophage Amplification platform technology. MicroPhage further announced that it has already begun OUS commercial shipments of the test.

5 Mar 2010

Study explores prognostic biomarkers in patients with lymph node-negative colorectal cancer

Tumor budding at the invasive tumor front of colorectal cancer is recognized as an independent prognostic factor significantly related to both lymph node and distant metastasis.

5 Mar 2010

Pregis announces expiration of Second Priority Senior Secured Floating Rate Notes due 2013 exchange offer

Pregis Corporation, a leading international manufacturer, marketer, and supplier of protective packaging products and specialty packaging solutions, today announced the expiration of its offer to exchange up to euro 125 million of its Second Priority Senior Secured Floating Rate Notes due 2013 issued in a private placement on October 5, 2009 for an equal principal amount of Second Priority Senior Secured Floating Rate Notes due 2013 that have been registered under the Securities Act of 1933, as amended.

5 Mar 2010

McKesson named "World's Most Admired" company and as one of 100 Best Corporate Citizens

McKesson Corporation, the nation’s largest healthcare services and information technology company, today was rated the "World's Most Admired" company in its industry in an annual survey conducted by FORTUNE magazine and the Hay Group. The company was also named one of the 100 Best Corporate Citizens by Corporate Responsibility Magazine.

5 Mar 2010

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

Liver transplantation specialists recently convened to address U.S. guidelines for allocation of organs for patients with hepatocellular carcinoma (HCC, liver cancer). Representatives from more than 130 U.S. transplant centers were invited to the conference and participants included 180 leaders in liver transplantation (LT) from the 50 most active centers.

5 Mar 2010

Data to advance the diagnosis, treatment and management of MH to be presented

Travel Award Available to share data with Clinicians and Scientists to advance the diagnosis, treatment, and management of Malignant Hyperthermia-Susceptible Patients April 23-24, 2010 at Mercy Hospital University of Pittsburgh Medical Center.

5 Mar 2010

Liberal government's radical health care restructuring plan will deny patients access to local care

Ontarians should be alarmed that the Liberal government is planning a radical restructuring of health care "premised not on quality of care and best practices, but solely on which hospital can do their surgeries most cheaply," says Michael Hurley, the president of the Ontario Council of Hospital Unions (OCHU) - which represents 30,000 CUPE hospital workers.

5 Mar 2010

Phase 1 clinical study of ISIS-SOD1Rx in patients with Lou Gehrig's disease commenced

Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 study of ISIS-SOD1Rx in patients with an inherited, aggressive form of Lou Gehrig's disease also known as familial amyotrophic lateral sclerosis (ALS).

5 Mar 2010

Hospital News and Research

Homecare advocates discuss the value and cost-effectiveness of home-based care

Study shows clear link between Vitamin D levels and accumulation of fat in muscle tissue

The Joint Commission provides 'The Gold Seal of Approval' to NYU Hospitals Center

Researchers assess clinical and cost impacts of PPI utilization in hospitalized patients

Postoperative complications more likely to occur at low-volume institutions

Inpatient integrative medicine program can have significant impact on pain: Study

Study reports increased incidence of colorectal cancer in China

Thymosin beta 4 improves neurological functional outcome

Closing small bowel stomas: Minimal delay optimal

Soluble Systems, SWAI launch TheraSkin to jumpstart healing in chronic and acute wounds

Investigators disprove reports that well-fed children are more vulnerable to dengue virus

XI to showcase HyGreen hand hygiene system at the Fifth Decennial International Conference

MicroPhage seeks FDA clearance for MRSA/MSSA Blood Culture Test, submits clinical study data

Study explores prognostic biomarkers in patients with lymph node-negative colorectal cancer

Pregis announces expiration of Second Priority Senior Secured Floating Rate Notes due 2013 exchange offer

McKesson named "World's Most Admired" company and as one of 100 Best Corporate Citizens

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

Data to advance the diagnosis, treatment and management of MH to be presented

Liberal government's radical health care restructuring plan will deny patients access to local care

Phase 1 clinical study of ISIS-SOD1Rx in patients with Lou Gehrig's disease commenced

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News